DS
DRW Securities Portfolio holdings
AUM
$1.42B
This Quarter Return
+1.9%
1 Year Return
+13.91%
3 Year Return
+34.48%
5 Year Return
+46.39%
10 Year Return
+76.71%
AUM
$1.51B
AUM Growth
+$1.51B
(+20%)
Cap. Flow
+$239M
Cap. Flow
% of AUM
15.83%
Top 10 Holdings %
Top 10 Hldgs %
97.16%
Holding
189
New
21
Increased
35
Reduced
15
Closed
78
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$323M |
| 2 |
SPDR Gold Trust
GLD
|
$28.8M |
| 3 |
iShares China Large-Cap ETF
FXI
|
$16.5M |
| 4 |
iShares MSCI India ETF
INDA
|
$15.9M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
$4.91M |
Top Sells
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
$41.7M |
| 2 |
Vanguard Total Bond Market
BND
|
$16.8M |
| 3 |
iShares MSCI Taiwan ETF
EWT
|
$10.2M |
| 4 |
iShares MSCI South Africa ETF
EZA
|
$6.8M |
| 5 |
iShares MSCI China ETF
MCHI
|
$6.45M |
Sector Composition
| 1 | Healthcare | 0.56% |
| 2 | Real Estate | 0.03% |
| 3 | Consumer Staples | 0.02% |
| 4 | Consumer Discretionary | 0.02% |
| 5 | Materials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Synlogic
SYBX
$17M
| $216K | 0.01% | 22,000 +3,000 | +16% | +$29.5K |
|
52
Adverum Biotechnologies
ADVM
$64.6M
| $212K | 0.01% | 40,000 +15,000 | +60% | +$79.5K |
|
|
GNCA
53
DELISTED
Genocea Biosciences, Inc.
GNCA
| $205K | 0.01% | +240,000 | New | +$205K |
|
54
Cartesian Therapeutics
RNAC
$261M
| $199K | 0.01% | 15,000 +3,000 | +25% | +$39.8K |
|
|
AFMD
55
DELISTED
Affimed
AFMD
| $198K | 0.01% | 120,000 +10,000 | +9% | +$16.5K |
|
|
ALPN
56
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $184K | 0.01% | 24,343 +14,143 | +139% | +$107K |
|
57
Protara Therapeutics
TARA
$120M
| $181K | 0.01% | 73,686 +20,000 | +37% | +$49.1K |
|
|
CFRX
58
DELISTED
ContraFect Corporation
CFRX
| $177K | 0.01% | 80,000 -30,000 | -27% | -$66.4K |
|
59
Aurinia Pharmaceuticals
AUPH
$1.58B
| $176K | 0.01% | 31,300 | – | – |
|
60
KalVista Pharmaceuticals
KALV
$678M
| $167K | 0.01% | 20,600 +5,600 | +37% | +$45.4K |
|
61
Larimar Therapeutics
LRMR
$310M
| $164K | 0.01% | 16,000 +5,000 | +45% | +$51.3K |
|
62
Gyre Therapeutics
GYRE
$703M
| $152K | 0.01% | +13,000 | New | +$152K |
|
63
Ovid Therapeutics
OVID
$91M
| $143K | 0.01% | 18,317 +3,000 | +20% | +$23.4K |
|
64
Aldeyra Therapeutics
ALDX
$351M
| $135K | 0.01% | 17,000 +5,000 | +42% | +$39.7K |
|
65
Eledon Pharmaceuticals
ELDN
$155M
| $129K | 0.01% | 18,489 +3,000 | +19% | +$20.9K |
|
66
ESSA Pharma
EPIX
$11.4M
| $128K | 0.01% | +33,857 | New | +$128K |
|
|
VBIV
67
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $126K | 0.01% | +45,898 | New | +$126K |
|
|
OMED
68
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $124K | 0.01% | 53,740 | – | – |
|
69
Qualigen Therapeutics
QLGN
$3.03M
| $111K | 0.01% | 43,310 +14,000 | +48% | +$35.9K |
|
70
Syndax Pharmaceuticals
SNDX
$1.41B
| $105K | 0.01% | +15,000 | New | +$105K |
|
71
PDS Biotechnology
PDSB
$57.8M
| $103K | 0.01% | 100,029 +50,000 | +100% | +$51.5K |
|
|
OTIC
72
DELISTED
Otonomy, Inc.
OTIC
| $96K | 0.01% | 25,000 +10,000 | +67% | +$38.4K |
|
|
RGLS
73
DELISTED
Regulus Therapeutics
RGLS
| $89K | 0.01% | 135,000 | – | – |
|
74
Tonix Pharmaceuticals
TNXP
$260M
| $89K | 0.01% | 20,000 | – | – |
|
|
NBRV
75
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $87K | 0.01% | 25,000 +4,000 | +19% | +$13.9K |
|